CHENGDU,China,Jan. 6,2025-- Technoderma Medicines,Inc. ("the Company"),a clinical stage biopharmaceutical company,is pleased to report the Company has completed its Phase 2a clinical trial (
01-08
The promotions span across six practice areas and three regions to drive growth in 2025 and beyond CHICAGO,Jan. 7,2025-- Heidrick & Struggles (Nasdaq: HSII),a premier provider of global leadershi
01-08
LAS VEGAS,Jan. 6,2025-- Merach,a fitness equipment brand dedicated to revolutionizing home workouts,has announced its participation in CES 2025.The brand will unveil its newly developed fitness game,F
01-08
LAS VEGAS,Jan. 7,2025-- TCL,a pioneer in display across feature-rich smartphones,tablets,and connected devices,today announced its latest NXTPAPER 4.0 technology at CES 2025,along with the TCL NXTPAPE
01-08
LAS VEGAS,Jan. 7,2025-- Digital Enhancement (Hangzhou) Co.,Ltd (hereafter referred to as "Digital Enhancement") is set to unveil the world\'s first commercial-grade Radio Processing Unit (RP
01-08
SHENZHEN,China,Jan. 7,2025-- Hypershell,a pioneer in PowerSuit based on Exoskeleton Technology,is excited to announce its attendance at CES 2025,building on the successful launch of the Hypershell X S
01-08
SINGAPORE,Jan. 7,2025--Mega Matrix Inc. (NYSE American: MPU) announced that it attended the China (Shanghai)-UAE Industry and Investment Cooperation Conference,themed "Exploring Overseas Markets
01-08
TORONTO,Jan. 7,2025-- Webull Canada,a subsidiary of Webull Corporation,the owner of the popular Webull digital investment platform,is proudly celebrating its first anniversary after a year of rapid g
01-08
Extends Connected Capital Ecosystem of Corporates and Bank Partners for Coverage Across the EU NEW YORK,Jan. 7,2025-- GSCF,a leading global provider of working capital solutions,today announced the
01-08
SINGAPORE and NEW YORK,Jan. 7,2025-- LingoAce,the global leader in online education for children with award-winning learning programs in Mandarin Chinese,English,and math,today announces the launch of
01-08
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
